We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Zotefoams Plc | LSE:ZTF | London | Ordinary Share | GB0009896605 | ORD 5P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
26.00 | 5.33% | 514.00 | 518.00 | 526.00 | 540.00 | 488.00 | 488.00 | 316,894 | 16:35:28 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
Plastics Foam Products | 126.98M | 9.24M | 0.1892 | 27.38 | 253.02M |
TIDMZTF
RNS Number : 5960Z
Zotefoams PLC
12 January 2024
Zotefoams plc
("Zotefoams" or "Company")
Director / PDMR Shareholding
12 January 2024 - Zotefoams, a world leader in cellular materials technology, announces that it has been informed that a number of transactions in ordinary shares of 5 pence each in the Company ("Ordinary Shares") have been undertaken on behalf of Gary McGrath, Chief Financial Officer, which includes a sale of Ordinary Shares out of a general investment account and subsequent purchase of Ordinary Shares into an ISA account for tax planning purposes. The table below sets out further information on the transactions, which in aggregate amounts to a net sale of 394 Ordinary Shares.
Following these transactions, Gary McGrath's beneficial interest in the Company is 100,492 Ordinary Shares, representing approximately 0.2% per cent. of the Company's issued share capital.
- Ends -
Enquiries:
Zotefoams plc +44 (0) 208 664 1600 David Stirling, Group CEO Gary McGrath, Group CFO IFC Advisory +44 (0) 203 934 6630 Graham Herring Tim Metcalfe Zach Cohen
The information below (set out in accordance with the requirements of EU Market Abuse Regulation) provides further detail:
1 Details of the person discharging managerial responsibilities/person closely associated a) Name Gary McGrath ================================ 2 Reason for the notification a) Position/status PDMR, Chief Financial Officer ================================ b) Initial notification Initial Notification /Amendment 3 Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor a) Name Zotefoams PLC b) LEI 213800B6P256B5XN8D32 ================================ 4 Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted a) Description of Ordinary Shares of 5 pence each the financial instrument, type of instrument Identification code ================================ b) Nature of the 1) Sale of Ordinary Shares transaction 2) Sale of Ordinary Shares 3) Sale of Ordinary Shares 4) Purchase of Ordinary Shares into Mr McGrath's ISA account c) Price(s) and volume(s) Price(s) Volume(s) 1) GBP2.6896 177 2) GBP3.0066 191 3) GBP3.3827 889 4) GBP3.4560 863 ================================ =============================== d) Aggregated information n/a - each a single transaction - Aggregated volume - Aggregated price e) Date of the transaction 1) 1 July 2022 2) 1 September 2022 3) 25 September 2023 4) 26 September 2023 ================================ f) Place of the transaction London Stock Exchange, Main Market (XLON) === ================================ ===============================================
About Zotefoams plc
Zotefoams plc (LSE - ZTF) is a world leader in cellular materials technology delivering optimal material solutions for the benefit of society. Utilising a variety of unique manufacturing processes, including environmentally friendly nitrogen expansion for lightweight AZOTE(R) polyolefin and ZOTEK(R) high-performance foams, Zotefoams sells to diverse markets worldwide. Zotefoams uses its own cellular materials to manufacture T-FIT(R) advanced insulation for demanding industrial markets. Zotefoams also owns and licenses patented microcellular foam technology to reduce plastic use in extrusion applications and for ReZorce(R) mono-material recyclable barrier packaging.
Zotefoams is headquartered in Croydon, UK, with additional manufacturing sites in Kentucky, USA and Brzeg, Poland (foam manufacture), Oklahoma, USA (foam products manufacture and conversion), Massachusetts, USA (MuCell Extrusion) and Jiangsu Province, China (T-FIT).
AZOTE(R) , ZOTEK(R) , ReZorce(R) and T-FIT(R) are registered trademarks of Zotefoams plc.
www.zotefoams.com
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
END
DSHEAKFAFSELEFA
(END) Dow Jones Newswires
January 12, 2024 12:13 ET (17:13 GMT)
1 Year Zotefoams Chart |
1 Month Zotefoams Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions